Fundamental research on prostate cancer demonstrated that neutrophils could bind to CTCs through intercellular adhesion molecule-1 to enhance the immune-killing resistance of CTCs to NK cells, thereby promoting the immune escape of CTCs (25). This evidence concerns the gene ICAM1 and prostate cancer.